Publication | Closed Access

A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group

UrologyOncologyMedicinePhase Ii StudyPharmacotherapyAnti-cancer AgentProstatic DiseasePharmacologyCancer ResearchEndocrine-related Cancer